SCHEMBL5444282

SCHEMBL5444282

Cc1ccccc1S(=O)(=O)OC(c1ccc(C#N)cc1)c1ccc(C#N)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.40
PRSS1 P07477 1/20 0.36
CTSG P08311 1/20 0.36
CTRB1 P17538 1/20 0.36
CMA1 P23946 1/20 0.36
TBXA2R P21731 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
ESR1 P03372 1/20 0.35
GAA P10253 1/20 0.35
ESR2 Q92731 1/20 0.35
SLC22A12 Q96S37 3/20 0.35
GRIA1 P42261 1/20 0.35
GRIA2 P42262 1/20 0.35
GRIA3 P42263 1/20 0.35
GRIA4 P48058 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5441065 0.77 ALDH1A1 (0.48) PRSS1MEN1KMT2AALDH1A1HPGD
SCHEMBL5435637 0.75 CA1 (0.42) KDM4EALDH1A1GAAGRIA1GRIA2
SCHEMBL4936612 0.71 MEN1 (0.44) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL14778954 0.71 MEN1 (0.44) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL28078215 0.70 MEN1 (0.43) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL5633234 0.69 TSHR (0.42) CASP6SLC22A12CYP2A6MAPT
SCHEMBL1196441 0.69 MEN1 (0.62) TBXA2RMEN1KMT2AKDM4EPOLB
SCHEMBL2892307 0.69 SLC22A12 (0.63) MEN1KMT2AALDH1A1SLC22A12CA1
SCHEMBL9913658 0.69 ALDH1A1 (0.40) PRSS1MEN1KMT2AALDH1A1CYP2A6
SCHEMBL10360517 0.68 KMT2A (0.42) MEN1KMT2AKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070100149-A1 PROCESS FOR PREPARING LETROZOLE DR. REDDY'S LABORATORIES, INC. 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100149-A1 PROCESS FOR PREPARING LETROZOLE CYP19A1, CYP2C19, CYP17A1 CASP6 650/4885PRSS1 291/4885CTSG 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.